BRANDY KHODR: Open Payments
NPI 1144730201 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,082 in 82 payments from 24 companies in 2025. Trend: 2023 $2,047 · 2024 $3,864 · 2025 $2,082
Food & beverage: $2,082
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $216 |
| Sumitomo Pharma America, Inc. | 10 | $201 |
| Dendreon Pharmaceuticals LLC | 6 | $193 |
| Endo USA, Inc. | 6 | $158 |
| Antares Pharma, Inc. | 11 | $150 |
| Janssen Biotech, Inc. | 5 | $119 |
| PFIZER INC. | 3 | $99 |
| Verity Pharmaceuticals Inc. | 4 | $94 |
| BIOTISSUE HOLDINGS INC. | 1 | $89 |
| UROGEN PHARMA, INC. | 2 | $84 |
Products named: Nubeqa, PROVENGE, XTANDI, AVEED, XYOSTED, GEMTESA, ERLEADA, PYLARIFY.
Industry payments across TX — which companies pay providers there.
